sopharma - Najnowsze wiadomości
2026-01-09 15:37SOPHARMA AD: Supplement to announcements under Art. 89t of the LPOS regarding the initial public offering of an issue of warrants with an exercise period of up to 3, 5 and 7 years, respectivelySpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:SFA_89t_ad_w_09012026_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word; box-sizing:...
2026-01-09 14:08SOPHARMA AD: Statement under Art. 32, para. 7 of the Law on the Introduction of the Euro in the Republic of Bulgaria (LIERB) regarding the initial public offering of an issue of warrants with an exercise period of up to 7 yearsSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:SFA_32_w7_09012025_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word; box-sizing:...
2026-01-09 14:02SOPHARMA AD: Announcement in accordance with art. 89t of the LPOS regarding the initiation of an initial public offering of an issue of warrants with an exercise period of up to 7 yearsSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:SFA_89t_w7_09012026 .rar td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word; box-sizing:...
2026-01-09 13:55SOPHARMA AD: Statement under Art. 32, para. 7 of the Law on the Introduction of the Euro in the Republic of Bulgaria (LIERB) regarding the initial public offering of an issue of warrants with an exercise period of up to 5 yearsSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:SFA_32_w5_09012025_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word; box-sizing:...
2026-01-09 13:51SOPHARMA AD: Announcement in accordance with art. 89t of the LPOS regarding the initiation of an initial public offering of an issue of warrants with an exercise period of up to 5 yearsSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:SFA_89t_w5_09012026.rar td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word; box-sizing:...
2026-01-09 13:41SOPHARMA AD: Statement under Art. 32, para. 7 of the Law on the Introduction of the Euro in the Republic of Bulgaria (LIERB) regarding the initial public offering of an issue of warrants with an exercise period of up to 3 yearsSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:SFA_32_w3_09012025_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word; box-sizing:...
2026-01-09 13:37SOPHARMA AD: Announcement in accordance with art. 89t of the LPOS regarding the initiation of an initial public offering of an issue of warrants with an exercise period of up to 3 yearsSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:SFA_89t_w3_09012026.rar td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word; box-sizing:...
2026-01-09 08:58SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_5_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word;...
2026-01-06 12:35SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_1_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word;...
2025-12-22 16:42SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_267_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-22 14:04SOPHARMA AD: Sales revenues for NovemberSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:SFA_Sales_Revenues_November_2025_EN_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-22 09:42SOPHARMA AD: Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" ADSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Donev investments holding_Sopharma_EN_2025.12.19Buy.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-22 09:24SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_264_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-19 12:25SOPHARMA AD: Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" ADSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Donev investments holding_Sopharma_EN_2025.12.18Buy.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-19 09:20SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_262_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-18 09:53SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_261_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-17 09:22SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_260_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-16 09:15SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_257_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-15 10:23SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_256_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...